Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for short stature: experimental growth hormone drug enters human trials

NCT ID NCT07450001

First seen Mar 26, 2026 · Last updated Jun 22, 2026 · Updated 18 times

Summary

This study tests a new medicine called GenSci134 in 128 children with growth hormone deficiency, a condition where the body doesn't make enough growth hormone, leading to slow growth. The study has two parts: first, a small group will get a single dose to check safety; second, a larger group will get multiple doses over time to see if it helps them grow taller compared to a standard treatment. The goal is to find the right dose and confirm it works well enough for a larger future study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC GROWTH HORMONE DEFICIENCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology

    Wuhan, Hubei, 430000, China

Conditions

The condition(s) this trial relates to.

isolated congenital growth hormone deficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.